CHA2 DS2 VASc score predicts unsuccessful electrical cardioversion in patients with persistent atrial fibrillation

Elzbieta Mlodawska1, Anna Tomaszuk-Kazberuk1, Paulina Lopatowska1

  • 1Department of Cardiology, Medical University of Bialystok, Bialystok, Poland.

Internal Medicine Journal
|November 19, 2016
PubMed

Insights

The CHA2DS2VASc score, commonly used for thrombotic risk, can predict the success of electrical cardioversion for atrial fibrillation (AF). Higher scores indicate a greater likelihood of unsuccessful cardioversion, offering a simple predictive tool.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Arrhythmology

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia affecting 2% of the population, significantly impacting morbidity and quality of life.
  • The CHA2DS2VASc score is a standard metric for assessing thrombotic risk in AF patients.
  • Previous research has not explored the CHA2DS2VASc score's utility in predicting electrical cardioversion outcomes.

Purpose of the Study:

  • To evaluate the predictive value of the CHA2DS2VASc score for unsuccessful electrical cardioversion in patients with persistent AF.
  • To determine if the CHA2DS2VASc score can serve as a reliable indicator of cardioversion success.

Main Methods:

  • A retrospective analysis of 258 consecutive patients undergoing electrical cardioversion for persistent AF between January 2012 and April 2016.
  • Calculation of CHA2DS2VASc and HAS-BLED scores for all included patients.
  • Statistical analysis to identify factors associated with unsuccessful cardioversion, including the CHA2DS2VASc score.

Main Results:

  • Electrical cardioversion was unsuccessful in 12% of the 258 patients studied.
  • Factors significantly associated with unsuccessful cardioversion included older age, history of ischemic stroke, male gender, and a higher CHA2DS2VASc score (P=0.002).
  • Patients with unsuccessful cardioversion had a significantly higher mean CHA2DS2VASc score (3.5) compared to those with successful cardioversion (2.4, P=0.001). A 1-point increase in CHA2DS2VASc score correlated with a 39% increase in the odds of unsuccessful cardioversion (OR 1.39).

Conclusions:

  • The CHA2DS2VASc score demonstrates potential as a simple, accessible, and effective tool for predicting the likelihood of unsuccessful electrical cardioversion in AF patients.
  • Routine assessment of the CHA2DS2VASc score may aid clinicians in managing patient expectations and planning cardioversion strategies.
Abstract

Related Concept Videos